Hamilton Morris

And the answer was kind of the obvious answer that everybody expected, which is that it was a full agonist at the mu opioid receptor.

For reasons that aren't fully understood, there are opioids that don't cause profound respiratory depression, relatively speaking. And for that reason, they... don't tend to cause fatal overdoses because that's the mechanism through which opioids exert their effect in terms of killing people is respiratory arrest.

For reasons that aren't fully understood, there are opioids that don't cause profound respiratory depression, relatively speaking. And for that reason, they... don't tend to cause fatal overdoses because that's the mechanism through which opioids exert their effect in terms of killing people is respiratory arrest.

For reasons that aren't fully understood, there are opioids that don't cause profound respiratory depression, relatively speaking. And for that reason, they... don't tend to cause fatal overdoses because that's the mechanism through which opioids exert their effect in terms of killing people is respiratory arrest.

I mean, I wouldn't want to make that claim. I wouldn't, you know, say, hey, if you're struggling with opioid dependence issues, transition onto TNF. That's not something that I'm saying. But conceivably, that would work. And that's also one of the things that Kratom is very popular for, is getting off of opioids.

I mean, I wouldn't want to make that claim. I wouldn't, you know, say, hey, if you're struggling with opioid dependence issues, transition onto TNF. That's not something that I'm saying. But conceivably, that would work. And that's also one of the things that Kratom is very popular for, is getting off of opioids.

I mean, I wouldn't want to make that claim. I wouldn't, you know, say, hey, if you're struggling with opioid dependence issues, transition onto TNF. That's not something that I'm saying. But conceivably, that would work. And that's also one of the things that Kratom is very popular for, is getting off of opioids.

Because when it comes to our methodology for treating opioid addiction in the United States— Pretty much the name of the game is simply replacement therapy. That's it. If you go to a doctor and you say, I have a problem using heroin, they'll give you methadone or they'll give you buprenorphine, both of which are opioids.

Because when it comes to our methodology for treating opioid addiction in the United States— Pretty much the name of the game is simply replacement therapy. That's it. If you go to a doctor and you say, I have a problem using heroin, they'll give you methadone or they'll give you buprenorphine, both of which are opioids.

Because when it comes to our methodology for treating opioid addiction in the United States— Pretty much the name of the game is simply replacement therapy. That's it. If you go to a doctor and you say, I have a problem using heroin, they'll give you methadone or they'll give you buprenorphine, both of which are opioids.

And the idea is just here is a safe, regular supply of an opioid that you can take every day that is considered to have a slightly lower abuse potential. But that's pretty much it.

And the idea is just here is a safe, regular supply of an opioid that you can take every day that is considered to have a slightly lower abuse potential. But that's pretty much it.

And the idea is just here is a safe, regular supply of an opioid that you can take every day that is considered to have a slightly lower abuse potential. But that's pretty much it.

Oh, certainly. Yeah, I think that's very much a possibility. One really important distinction that I want to make is that I think there is a huge difference between giving someone an opioid that they recognize is an opioid and providing something deceptively where they don't know what they are consuming. That is unacceptable. And unfortunately, it is incentivized by the existing legal framework.

Oh, certainly. Yeah, I think that's very much a possibility. One really important distinction that I want to make is that I think there is a huge difference between giving someone an opioid that they recognize is an opioid and providing something deceptively where they don't know what they are consuming. That is unacceptable. And unfortunately, it is incentivized by the existing legal framework.

Oh, certainly. Yeah, I think that's very much a possibility. One really important distinction that I want to make is that I think there is a huge difference between giving someone an opioid that they recognize is an opioid and providing something deceptively where they don't know what they are consuming. That is unacceptable. And unfortunately, it is incentivized by the existing legal framework.

So if you were to say, hey, this is an opioid and it has this or that risks associated with its use and you should use it in the following way, that would potentially make it impossible to sell.

So if you were to say, hey, this is an opioid and it has this or that risks associated with its use and you should use it in the following way, that would potentially make it impossible to sell.

So if you were to say, hey, this is an opioid and it has this or that risks associated with its use and you should use it in the following way, that would potentially make it impossible to sell.